Provided by Tiger Trade Technology Pte. Ltd.

Insmed

106.24
-3.2900-3.00%
Post-market: 106.260.0200+0.02%19:56 EDT
Volume:2.43M
Turnover:260.45M
Market Cap:22.90B
PE:-18.62
High:110.83
Open:108.47
Low:106.20
Close:109.53
52wk High:212.75
52wk Low:65.56
Shares:215.55M
Float Shares:193.00M
Volume Ratio:0.68
T/O Rate:1.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.7044
EPS(LYR):-6.4200
ROE:-294.46%
ROA:-31.11%
PB:32.49
PE(LYR):-16.55

Loading ...

Company Profile

Company Name:
Insmed
Exchange:
NASDAQ
Establishment Date:
1988
Employees:
1664
Office Location:
700 US Highway 202/206,Bridgewater,New Jersey,United States
Zip Code:
08807
Fax:
- -
Introduction:
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary hypertension associated with interstitial lung disease and pulmonary arterial hypertension. The company was founded in 1988 and is headquartered in Bridgewater, New Jersey.

Directors

Name
Position
William H. Lewis
Director,Chair of the Board and Chief Executive Officer
Carol A. Schafer
Independent Director
Clarissa Desjardins
Independent Director
David R. Brennan
Lead Independent Director
Elizabeth McKee Anderson
Independent Director
Leo Lee
Independent Director
Melvin Sharoky
Independent Director

Shareholders

Name
Position
William H. Lewis
Director,Chair of the Board and Chief Executive Officer
Roger Adsett
Chief Operating Officer
Sara Bonstein
Chief Financial Officer
Martina Flammer
Chief Medical Officer
Michael A. Smith
Chief Legal Officer
S. Nicole Schaeffer
Chief People Strategy Officer